Moreover, low levels of creatinine are associated with higher mortality rate in melanoma patients as demonstrated in a retrospective cohort study where low serum creatinine levels were associated with worse survival in 139 melanoma cancer patients treated with anti-PDL-1 and anti-CTL4 (Naik et al., 2019). This evidence concerns the gene CD274 and melanoma.